BioNJ Announces Lineup for BioPartnering Conference

News provided by

Apr 25, 2024, 14:27 ET

TRENTON, N.J., April 25, 2024 /PRNewswire/ -- BioNJ is pleased to host its 14th Annual BioPartnering Conference on Tuesday, May 14, at the Liberty Science Center in Jersey City. Sponsored by J.P. Morgan, Johnson & Johnson and Morgan Lewis and hosted by Jersey City Economic Development Corp., the Conference will bring together life sciences executives, investors, strategics, academic collaborators and business development professionals for 1-1 partnering, Industry Connections (office hours with large biopharma companies), exhibits, company pitch presentations, plenary sessions and lots of networking -- including a closing networking reception.

The action-packed schedule is designed to create meaningful opportunities, grow the ecosystem and bolster medical innovation. Timely plenary sessions will include:

Industry Overview: Key Trends & Outlook
BioPartnering: Keys to Success for Biotech and Pharma Partnerships
How Biopharma Companies are Using AI to Accelerate Innovation
Venture Capital's New Era: Dynamic Shifts and Future Trends

And, featuring thought leaders, such as:

Tyler Bryk, Head of Artificial Intelligence, PTC Therapeutics
Samuele Butera, President, U.S. Pulmonary Hypertension & Retina, Johnson & Johnson & Board Member, BioNJ
Kim Cato, MBA, Vice President, Information Technology, Thermo Fisher Scientific
Steven M. Cohen, J.D., Partner, Morgan Lewis
Alma DeMetropolis, CFA, CPF, Managing Director, J.P. Morgan Asset & Wealth Management
Jersey City Mayor Steven Fulop
David Schwartz, J.D., Partner & Leader, Corporate & Business Transaction Practice, Morgan Lewis
Jim Gunton, MBA, Managing Partner & Founder, Tech Council Ventures
Don Hass, J.D., Vice President, Head, Genetic Medicine Business Development, Regeneron Pharmaceuticals
Jenna Hebert, Ph.D., Senior Venture Associate, RA Capital
Paul Hoffman, President, Liberty Science Center
Sophie Jones, M.D., Managing Director, J.P. Morgan, Healthcare Investment Banking
Alan Leeds, J.D., Partner & Co-Leader, Global Life Sciences Practice, Morgan Lewis Partner
Nancy Ondovik, MBA, Pharm.D., Principal, New Company Creation, Johnson & Johnson
Emilio Ragosa, J.D., Managing Partner, DLA Piper
Hal Stern, Vice President & Chief Information Officer, R&D, Johnson & Johnson Innovation Medicine
Phil Tinmouth, MBA, Chief Business Officer, Mammoth Biosciences

In addition, attendees can schedule 10-minute appointments at the Industry Connections Desk offering one-on-one time with BD professionals from large biopharma companies, such as Ferring Pharmaceuticals, Johnson & Johnson, Merck & Co., Pfizer, Sanofi and Teva Pharmaceuticals.

"The BioPartnering Conference is the ideal chance to discover innovative companies for investment portfolios," BioNJ President and CEO Debbie Hart noted. "We have more than 90 companies from the life sciences, biotech, healthcare and digital health sectors presenting new innovations and technologies. With the One-on-One Partnering System open, attendees can begin scheduling meetings to explore collaboration opportunities."

Emerging companies that will be presenting include:

4M Therapeutics
Accelerated Biosciences
ACON Pharmaceuticals
Adiso Therapeutics
AGelity Biomechanics
AOA Dx
ArrePath
Ascent Bio
Aspargo Labs
Avistone Biotechnology
Benevira
BioCentriq
Canget BioTekpharma
Couragene
DevaCell
Enalare Therapeutics
EpiBone
FrontAim Biomedicines
Hanimune Therapeutics
Iktos
Illuminare Biotechnologies
Intrommune Therapeutics
Jubilant Therapeutics
KayoThera
Lactiga US
Merlin Biotech
NanomediGene
NemaGen Discoveries
Neuropathix
NuraLogix
Panavance Therapeutics
Partex
PharmaNest
Regenosine
Ricovr Healthcare
Rx Bandz
Sen-Jam Pharmaceutical
Sentauri
Sentrimed
SFA Therapeutics
Signum Biosciences
SkunkWorx Bio
Soligenix
Somnia Therapeutics
Synthis Therapeutics
Taxis Pharmaceuticals
TelomEye Pharmaceuticals
Thread Bioscience
Torigen
Vaxine USA
ViCardia Therapeutics
Vital Start Health
Vuja De Sciences
Xenon Ophthalmics
Xiconic Pharmaceuticals
Ziphius

Early stage start-up pitches include:

6S Pharma
Abonics
Addinex Technologies
Advent Therapeutics
Aperture Bio
Azome Therapeutics
BioLattice Ophthalmics
Clinical Trials
Delphine Diagnostics
Dimer Health
Hongyi Therapeutics
HopeAI
Inaedis
Innerstill
InteguRx Therapeutics
Kognitic
KolateAI PharmaTech
LumaCell
Materialize Bio
Mechano Therapeutics
Monarch Therapeutics
Neoventech
NeuroPair
OLI Technologies
Orbits Oncology
Pression
Prima Innovations
SciMar ONE
Synergy Therapeutics
tenXclinical
TRIZ Bio Pharma
Vasowatch
VITRUVIAE
Zena Therapeutics

Conference attendees will have the opportunity to meet with a wide variety of exhibitors showcasing valuable resources, products and services available to the BioNJ community, including:

Advant-Edge
Amicus Therapeutics
AscellaHealth
Ascendia Pharmaceuticals
BioBridges
BOME Pharma
CFGI
Datasite
DLA Piper
Fedsprout
GenVault
Grant Thornton
Jersey City Economic Development Corp.
Johnson & Johnson
J.P. Morgan
Marcum
Middlesex County
Morgan Lewis
NJ Commission on Science, Innovation & Technology
NJ Israel Commission
NJ Economic Development Authority
NJ Health Foundation
Princeton BioLabs
Thermo Fisher
Withum

"We look forward to welcoming BioNJ's preeminent 2024 BioPartnering Conference to the Liberty Science Center and introducing attendees to SciTech Scity, the 30-acre innovation campus we are now building that will focus on biomedical science, home healthcare, planet care and artificial intelligence," said Paul Hoffman, President and CEO, Liberty Science Center and SciTech Scity.

Register and find additional information at BioNJ.org/BioPartnering. Registration is $425 for BioNJ Members and $525 for Future BioNJ Members. Last year's BioPartnering Conference brought together nearly 600 attendees from 16 states and 16 countries as well as the District of Columbia.

Media Contact
Randi Bromberg
Sr. Vice President, Communications and Marketing
O) 609-890-3185
C) 609-955-1067
[email protected]

SOURCE BioNJ